Results 91 to 100 of about 749 (180)

Prognostic Value of Molecular Aberrations in Low- or Intermediate-Risk Neuroblastomas: A Systematic Review. [PDF]

Cancers (Basel)
Bruinsma RS, Lekkerkerker CWM, Fiocco M, Dierselhuis MP, Langenberg KPS, Tytgat GAM, van Noesel MM, Wijnen MHWA, van der Steeg AFW, de Krijger RR.   +9 more
europepmc   +1 more source

International neuroblastoma risk group consortium: a model of networking for rare cancers. [PDF]

J Natl Cancer Inst
Cohn SL, London WB, Schleiermacher G, Moreno L, Ambros IM, Ambros PF, Bagatell R, Popovic MB, Beiske KH, Berthold F, Birz S, Brisse HJ, Brodeur GM, Brock PR, Burchill S, Eggert A, Federico SM, Fischer M, Furner BT, Hero B, Machin D, Kamijo T, Matthay KK, Nakagawara A, Naranjo A, Pötschger U, Valteau-Couanet D, Watkins MT, Irwin MS, Volchenboum SL, Park JR, Pearson ADJ.   +31 more
europepmc   +1 more source

Single-cell transcriptomics reveals shared immunosuppressive landscapes of mouse and human neuroblastoma. [PDF]

J Immunother Cancer, 2022
Costa A, Thirant C, Kramdi A, Pierre-Eugène C, Louis-Brennetot C, Blanchard O, Surdez D, Gruel N, Lapouble E, Pierron G, Sitbon D, Brisse H, Gauthier A, Fréneaux P, Bohec M, Raynal V, Baulande S, Leclere R, Champenois G, Nicolas A, Meseure D, Bellini A, Marabelle A, Geoerger B, Mechta-Grigoriou F, Schleiermacher G, Menger L, Delattre O, Janoueix-Lerosey I.   +28 more
europepmc   +1 more source

Leben Schleiermachers

, 1870
Jugendjahre und erste Bildung, 1768-1796 -- Fülle des Lebens. Die Epoche der anschaulichen Darstellung seiner Weltanschauung, 1796-1802 -- Denkmale der inneren Entwicklung Schleiermachers erläutert duch kritische ...
openaire   +2 more sources

Correction to: The pitfalls and promise of liquid biopsies for diagnosing and treating solid tumors in children: as review. [PDF]

Eur J Pediatr, 2020
Van Paemel R, Vlug R, De Preter K, Van Roy N, Speleman F, Willems L, Lammens T, Laureys G, Schleiermacher G, Tytgat GAM, Astrahantseff K, Deubzer H, De Wilde B.   +12 more
europepmc   +1 more source

Public health authorities in Germany during the SARS-CoV-2 pandemic - a constructive-critical reflection. [PDF]

GMS Hyg Infect Control
Heudorf U, Gottschalk R.
europepmc   +1 more source

Reversible transitions between noradrenergic and mesenchymal tumor identities define cell plasticity in neuroblastoma. [PDF]

Nat Commun, 2023
Thirant C, Peltier A, Durand S, Kramdi A, Louis-Brennetot C, Pierre-Eugène C, Gautier M, Costa A, Grelier A, Zaïdi S, Gruel N, Jimenez I, Lapouble E, Pierron G, Sitbon D, Brisse HJ, Gauthier A, Fréneaux P, Grossetête S, Baudrin LG, Raynal V, Baulande S, Bellini A, Bhalshankar J, Carcaboso AM, Geoerger B, Rohrer H, Surdez D, Boeva V, Schleiermacher G, Delattre O, Janoueix-Lerosey I.   +31 more
europepmc   +1 more source

Use Cases Requiring Privacy-Preserving Record Linkage in Paediatric Oncology. [PDF]

Cancers (Basel)
Hayn D, Kreiner K, Sandner E, Baumgartner M, Jammerbund B, Falgenhauer M, Düster V, Devi-Marulkar P, Schleiermacher G, Ladenstein R, Schreier G.   +10 more
europepmc   +1 more source

Diagnosis and Management of Opsoclonus-Myoclonus-Ataxia Syndrome in Children: An International Perspective. [PDF]

Neurol Neuroimmunol Neuroinflamm, 2022
Rossor T, Yeh EA, Khakoo Y, Angelini P, Hemingway C, Irani SR, Schleiermacher G, Santosh P, Lotze T, Dale RC, Deiva K, Hero B, Klein A, de Alarcon P, Gorman MP, Mitchell WG, Lim M, OMS Study Group.   +17 more
europepmc   +1 more source

Mutated FGFR1 is an oncogenic driver and therapeutic target in high-risk neuroblastoma. [PDF]

J Clin Invest
Werr L, Boland J, Petersen J, Iglesias F, Höppner S, Bartenhagen C, Rosswog C, Hellmann AM, Kahlert Y, Hemstedt N, Ibruli N, Dammert MA, Decarolis B, Werner JM, Malchers F, Schramm K, Witt O, Beiske KH, Rognlien AGW, Gunnes MW, Langenberg KP, Molenaar J, Bernkopf M, Taschner-Mandl S, Hughes D, George SL, Chesler L, Schulte JH, Barone G, Capasso M, Surrey LF, Bagatell R, Masliah-Planchon J, Schleiermacher G, Grüll H, Westermann F, Schultheis AM, Büttner R, Henssen AG, Eggert A, Peifer M, Shukla NN, Simon T, Hero B, Reinhardt HC, Thomas RK, Fischer M.   +46 more
europepmc   +1 more source